Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

17 results about "Peripheral thrombosis" patented technology

Thrombosis is generally defined by the type of blood vessel affected (arterial or venous thrombosis) and the precise location of the blood vessel or the organ supplied by it. Deep vein thrombosis (DVT) is the formation of a blood clot within a deep vein. It most commonly affects leg veins, such as the femoral vein.

Traditional Chinese medicine composition capable of dredging collaterals and removing thrombus for preventing and treating stroke, vascular thrombus, arteriosclerosis, coronary heart disease or waist and leg pain

The invention relates to a collateral-dredging thrombus-removing traditional Chinese medicine composition for preventing and treating stroke, vascular thrombus, arteriosclerosis, coronary heart disease or waist and leg pain. The traditional Chinese medicine composition is prepared from the following raw material medicines in parts by weight: 12-65 parts of cooked rhubarb, 10-72 parts of salvia miltiorrhiza, 12-65 parts of cortex moutan, 6-57 parts of rhizoma zingiberis, 8-50 parts of pseudo-ginseng, 15-45 parts of obscured homalomena rhizome, 10-68 parts of leech, 7-76 parts of earthworm, 15-70 parts of ligusticum wallichii, 6-52 parts of Tibetan capillary artemisia, 7-49 parts of cape jasmine, 3-25 parts of borneol, 6-75 parts of angelica sinensis, 12-65 parts of ginseng, 7-53 parts of pogostemon cablin and 10-77 parts of radix curcumae. The medicine has the effects of promoting blood circulation, removing blood stasis, dredging collaterals and removing thrombus. The traditional Chinese medicine composition can be used for preparing medicines for treating cerebral apoplexy, coronary heart disease, arteriosclerosis and static artery thrombosis diseases, or medicines for soothing channels, activating collaterals and promoting blood circulation to remove blood stasis, which are related to waist and leg pain diseases. The invention provides a prevention and treatment effective solution for people with stroke, vascular thrombosis, arteriosclerosis, coronary heart disease or waist and leg pain.
Owner:HUNAN ZHONGYU PHARMACEUTICAL CO LTD

Energy delivery systems and uses thereof

The present invention relates to comprehensive systems, devices and methods for delivering energy to tissue for a wide variety of applications, including medical procedures (e.g., tissue ablation, resection, cautery, vascular thrombosis, treatment of cardiac arrhythmias and dysrhythmias, electrosurgery, tissue harvest, etc.). In certain embodiments, systems, devices, and methods are provided for treating a tissue region (e.g., a tumor) through application of energy.
Owner:NEUWAVE MEDICAL INC

5 / 8 / 5 chitin diterpenoid compound, biosynthetic gene cluster and application of biosynthetic gene cluster

ActiveCN121337787AFungiOrganic chemistryHeterologousInduced platelet aggregation
The invention discloses a 5 / 8 / 5 chitosan clostridium diterpenoid compound, a biosynthetic gene cluster and application of the biosynthetic gene cluster, and relates to the technical field of biological medicines. A 5 / 8 / 5 chitin type diterpenoid biosynthetic gene cluster Thm in trichoderma harzianum is identified through a genome mining system, chitin diterpenoid compounds with diversified structures are obtained by means of heterologous expression, the obtained compounds are subjected to anti-thrombotic activity comprehensive evaluation, and the result shows that the compounds 6 and 31 can obviously inhibit vascular thrombosis, the compound 6 has a remarkable inhibition effect on collagen-induced platelet aggregation, and the compound 31 has a better inhibition capability on thrombin-induced platelet activation. The compounds 6 and 31 show powerful antithrombotic effects in artery, vein and pulmonary artery thrombosis models, so that powerful technical support is provided for development of antithrombotic drugs.
Owner:HUAZHONG UNIV OF SCI & TECH

Energy delivery systems and uses thereof

The present invention relates to comprehensive systems, devices and methods for delivering energy to tissue for a wide variety of applications, including medical procedures (e.g., tissue ablation, resection, cautery, vascular thrombosis, treatment of cardiac arrhythmias and dysrhythmias, electrosurgery, tissue harvest, etc.). In certain embodiments, systems, devices, and methods are provided for delivering energy to difficult to access tissue regions (e.g. peripheral lung tissues), and / or reducing the amount of undesired heat given off during energy delivery.
Owner:NEUWAVE MEDICAL INC

Energy delivery systems and uses thereof

Provided herein are devices, systems, and methods for delivering energy to tissue for a wide variety of applications, including medical procedures (e.g., tissue ablation, resection, cautery, vascular thrombosis, treatment of cardiac arrhythmias and dysrhythmias, electrosurgery, tissue harvest, etc.). In certain embodiments, devices, systems, and methods are provided for delivering energy to difficult to access tissue regions (e.g. central or peripheral lung tissues), and / or reducing the amount of undesired heat given off during energy delivery.
Owner:NEUWAVE MEDICAL INC

Energy delivery devices with flexible and adjustable tips

The present invention relates to comprehensive systems, devices and methods for delivering energy to tissue for a wide variety of applications, including medical procedures (e.g., tissue ablation, resection, cautery, vascular thrombosis, treatment of cardiac arrhythmias and dysrhythmias, electrosurgery, tissue harvest, etc.). In particular, systems, devices, and methods are provided for treating a tissue region (e.g., a tumor) through application of energy using energy delivery devices with flexible and adjustable tips.
Owner:NEUWAVE MEDICAL INC

Factor xii binding peptides and methods of use

PCT designated stage expiredWO2025006536A2Peptide/protein ingredientsBlood disorderDiseaseBinding peptide
Disclosed herein, are peptides that bind coagulation factor XII (FXII). Also described herein, are methods of administering compounds comprising peptides that bind coagulation FXII to subjects for the treatment of cancer-associated thrombosis, sickle cell disease associated with vaso-occlusive crisis or vascular thrombosis, colon cancer, glioblastoma multiforme, organ fibrosis, Alzheimer's disease, and autoimmune encephalitis.
Owner:THE UNITED STATES OF AMERICA AS REPRESENTED BY THE DEPT OF VETERANS AFFAIRS +1

Energy delivery systems and uses thereof

Provided herein are devices configured for tissue ablation having hollow inner conductors for distal tip sensing access. In particular, energy delivery devices are provided having one or more sensors (e.g., positioning sensors, temperature sensors) positioned outside the distal end of a hollow inner conductor (e.g., within a region configured for ablation energy emission). In certain embodiments, such devices are utilized in systems and methods for delivering energy to tissue for a wide variety of applications, including medical procedures (e.g., tissue ablation, resection, cautery, vascular thrombosis, treatment of cardiac arrhythmias and dysrhythmias, electrosurgery, tissue harvest, etc.).
Owner:NEUWAVE MEDICAL INC

A near-infrared femtosecond laser-induced vascular embolization system

The present invention discloses a near-infrared femtosecond laser simulation-induced vascular embolism system. Rose Bengal reagent is pre-injected into the cerebral cortical blood vessels; the femtosecond laser is stimulated to generate a specific near-infrared 1070nm femtosecond laser and is incident on the two-photon microscope system to focus on the cerebral cortical blood vessel area of ​​interest; repeated spiral rapid scanning stimulation is performed in the area of ​​interest ROI to form a thrombus, and the imaging laser is also processed to generate an imaging beam and focused on the cerebral cortical blood vessels for real-time vascular imaging; the imaging laser generates an imaging beam and is incident on the two-photon microscope system; the stimulating femtosecond laser and the imaging laser are controlled to work according to the scanning imaging sequence. The present invention combines 1070nm near-infrared femtosecond laser stimulation with two-photon microscopic imaging technology to achieve precise and rapid thrombosis of blood vessels of various types, sizes and depths. It is a new and more effective system for the formation of targeted vascular thrombus, which is fast, accurate and has depth selectivity.
Owner:ZHEJIANG UNIV

Compositions and methods for detecting and treating thrombosis and vascular plaques

The present invention provides nanodroplets labeled with targeting ligands that can be used to detect and treat vascular thrombosis (e.g., fibrin clots) and vascular plaques, or related diseases and disorders, as well as methods of making and using the same.
Owner:MICROVASCULAR THERAPEUTICS LLC

Energy delivery systems and uses thereof

Provided herein are devices, systems, and methods for delivering energy to tissue for a wide variety of applications, including medical procedures (e.g., tissue ablation, resection, cautery, vascular thrombosis, treatment of cardiac arrhythmias and dysrhythmias, electrosurgery, tissue harvest, etc.). In certain embodiments, devices, systems, and methods are provided for delivering energy to difficult to access tissue regions (e.g. central or peripheral lung tissues), and / or reducing the amount of undesired heat given off during energy delivery.
Owner:NEUWAVE MEDICAL INC

System for predicting rupture or detachment of vascular plaques that could lead to a stroke and / or for predicting vascular thrombosis

A system for predicting at least partial rupture or detachment of a vascular plaque that may lead to a stroke or for analyzing the biomechanical properties of the wall of an internal jugular vein in order to predict a risk of thrombosis, comprising: a monitoring device (2) including a temperature sensor (5) configured to measure the temperature of the vascular plaque or the wall of the jugular vein, a vibration sensor (4) configured to measure mechanical waves passing through the vascular plaque and the underlying walls, a motion sensor (6) configured to measure the movements of the plaque or the wall of the jugular vein (6), an electrical sensor configured to measure a parameter related to the electrical impedance of the plaque, an acoustic wave sensor, and a computing unit (10) configured to analyze the data from the monitoring device (2) by artificial intelligence.Figure from the summary: Figure 1.
Owner:OCTOGONE MEDICAL

Factor xii binding peptides and methods of use

Disclosed herein, are peptides that bind coagulation factor XII (FXII). Also described herein, are methods of administering compounds comprising peptides that bind coagulation FXII to subjects for the treatment of cancer-associated thrombosis, sickle cell disease associated with vaso-occlusive crisis or vascular thrombosis, colon cancer, glioblastoma multiforme, organ fibrosis, Alzheimer's disease, and autoimmune encephalitis.
Owner:THE UNITED STATES OF AMERICA AS REPRESENTED BY THE DEPT OF VETERANS AFFAIRS +1

Apparatus for treating vascular thrombosis by ultrasounds

An apparatus for treating vascular thrombosis with ultrasound, comprising: - a therapeutic ultrasonic transducer (TUT), suitable for generating focused ultrasonic waves (OUF) that propagate along an emission axis (AE); - an imaging ultrasonic transducer (TUI) associated with the therapeutic transducer; - a means (SMDR, FEF) for moving the focal spot of the therapeutic ultrasonic transducer along the emission axis with respect to the imaging transducer; - a motorized mechanical system (SMM) for translating the transducers along at least a first axis (AD1) parallel to said emission axis and a second axis (AD2) perpendicular to the first; and - an electronic control system (SEC) for driving the motorized mechanical system and the means for moving the focal spot of the therapeutic transducer.
Owner:CARDIAWAVE

Energy delivery systems and uses thereof

The present invention relates to systems and devices for delivering energy to tissue for a wide variety of applications, including medical procedures (e.g., tissue ablation, resection, cautery, vascular thrombosis, treatment of cardiac arrhythmias and dysrhythmias, electrosurgery, tissue harvest, etc.). In particular, the present invention relates to systems and devices for the delivery of energy with a linear array of antenna components having optimized energy delivery characteristics. In certain embodiments, methods are provided for treating a tissue region (e.g., a tumor) through application of energy with the systems and devices of the present invention.
Owner:NEUWAVE MEDICAL INC